Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 4Completed 4Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1Dermatologic 1CNS 1

Conditions

Thyroid Cancer, Papillary 15Neuroendocrine Tumors 14Carcinoma, Neuroendocrine 9Pituitary Neoplasms 8Thyroid Neoplasms 6Pheochromocytoma 6Thyroid Carcinoma, Anaplastic 4Paraganglioma 4Neoplasms 4Multiple Endocrine Neoplasia Type 1 3Recurrence 2Rectal Neuroendocrine Tumor 2Neoplasm Metastasis 2Melanoma 2Cushing Syndrome 2Adenocarcinoma, Follicular 2Acromegaly 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Thyroid cancer, medullary 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Serotonin Syndrome 1Sarcoma 1SDH-Related Familial Paraganglioma 1Rectal Neuroendocrine Tumors 1Rectal Neoplasms 1Prostatitis 1Prostatic Neoplasms 1Pituitary Diseases 1

Interventions

trametinib 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasms by Site × Endocrine × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡